| Comprehensive molecular characterization of urothelial bladder carcinoma CGAR Network Nature, 2014 | 2629 | 2014 |
| Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology JS Damrauer, KA Hoadley, DD Chism, C Fan, CJ Tiganelli, SE Wobker, ... Proceedings of the national academy of sciences 111 (8), 3110-3115, 2014 | 906 | 2014 |
| Cancer cachexia is regulated by selective targeting of skeletal muscle gene products S Acharyya, KJ Ladner, LL Nelsen, J Damrauer, PJ Reiser, S Swoap, ... The Journal of clinical investigation 114 (3), 370-378, 2004 | 647 | 2004 |
| Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling RL Chandler, JS Damrauer, JR Raab, JC Schisler, MD Wilkerson, ... Nature communications 6 (1), 6118, 2015 | 312 | 2015 |
| Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia JS Damrauer, ME Stadler, S Acharyya, AS Baldwin, ME Couch, ... European journal of translational myology 28 (2), 2018 | 181 | 2018 |
| Comprehensive analysis of genetic ancestry and its molecular correlates in cancer J Carrot-Zhang, N Chambwe, JS Damrauer, TA Knijnenburg, ... Cancer Cell 37 (5), 639-654. e6, 2020 | 176 | 2020 |
| CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors A Walens, AV DiMarco, R Lupo, BR Kroger, JS Damrauer, JV Alvarez Elife 8, e43653, 2019 | 166 | 2019 |
| The IκB kinases IKKα and IKKβ are necessary and sufficient for skeletal muscle atrophy D Van Gammeren, JS Damrauer, RW Jackman, SC Kandarian The FASEB Journal 23 (2), 362, 2009 | 129 | 2009 |
| B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres D Nehama, N Di Ianni, S Musio, H Du, M Patané, B Pollo, G Finocchiaro, ... EBioMedicine 47, 33-43, 2019 | 121 | 2019 |
| Molecular subtype-specific immunocompetent models of high-grade urothelial carcinoma reveal differential neoantigen expression and response to immunotherapy R Saito, CC Smith, T Utsumi, LM Bixby, J Kardos, SE Wobker, KG Stewart, ... Cancer research 78 (14), 3954-3968, 2018 | 99 | 2018 |
| FOXM1 deubiquitination by USP21 regulates cell cycle progression and paclitaxel sensitivity in basal-like breast cancer A Arceci, T Bonacci, X Wang, K Stewart, JS Damrauer, KA Hoadley, ... Cell reports 26 (11), 3076-3086. e6, 2019 | 74 | 2019 |
| Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal B Zhou, JS Damrauer, ST Bailey, T Hadzic, Y Jeong, K Clark, C Fan, ... The Journal of clinical investigation 124 (2), 553-563, 2014 | 74 | 2014 |
| Ancestry-specific predisposing germline variants in cancer N Oak, AD Cherniack, RJ Mashl, FR Hirsch, L Ding, R Beroukhim, ... Genome medicine 12, 1-15, 2020 | 38 | 2020 |
| Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence A Walens, J Lin, JS Damrauer, B McKinney, R Lupo, R Newcomb, DB Fox, ... Nature communications 11 (1), 5017, 2020 | 32 | 2020 |
| mTOR inhibition induces compensatory, therapeutically targetable MEK activation in renal cell carcinoma ST Bailey, B Zhou, JS Damrauer, B Krishnan, HL Wilson, AM Smith, M Li, ... PLoS One 9 (9), e104413, 2014 | 32 | 2014 |
| Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway J Carrot-Zhang, X Yao, S Devarakonda, A Deshpande, JS Damrauer, ... Cell reports 34 (5), 2021 | 28 | 2021 |
| Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer JS Damrauer, KR Roell, MA Smith, X Sun, EL Kirk, KA Hoadley, ... Clinical Cancer Research 27 (16), 4599-4609, 2021 | 26 | 2021 |
| Foxo-dependent Par-4 upregulation prevents long-term survival of residual cells following PI3K–Akt inhibition JS Damrauer, SN Phelps, K Amuchastegui, R Lupo, NW Mabe, A Walens, ... Molecular Cancer Research 16 (4), 599-609, 2018 | 19 | 2018 |
| Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer JS Damrauer, W Beckabir, J Klomp, M Zhou, ER Plimack, MD Galsky, ... Nature communications 13 (1), 6658, 2022 | 14 | 2022 |
| In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators JL Franks, RC Martinez-Chacin, X Wang, RL Tiedemann, T Bonacci, ... PLoS biology 18 (12), e3000975, 2020 | 12 | 2020 |
